Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials
Richard S.E. Keefe, Philip D Harvey, Christoph U Correll, Peter Falkai, Naoki Hashimoto, Hans Klein, John H. Krystal, Stephen R. Marder, Alice Medalia, Tomiki Sumiyoshi, Gang Wang, Hongyan Zhang, Zuzana Blahova, Ingrid Bichard-Sall, Brett A. English, Eric Fu, Fredrik Gruenenfelder, Martina Groeschl, Karen Kimura, Wenbo Tang, Christoph von der Goltz, Corey Fowler
Topics & Concepts
Schizophrenia (object-oriented programming)MedicineCognitive impairmentPsychiatryMEDLINEPhase (matter)CognitionRandomized controlled trialClinical trialPsychosisPhysical therapyInternal medicineMeta-analysisPhysical medicine and rehabilitationClinical psychologyPhases of clinical researchSchizophrenia spectrumRisk assessmentSeverity of illnessYoung adultSchizophrenia research and treatmentPhosphodiesterase function and regulationDementia and Cognitive Impairment Research